Is there a correlation between CRP and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?;Korrelieren C-reaktives protein und verkalkungs-inhibitoren bei hämodialyse-patienten mit kardiovaskulären parametern und risikofaktoren?

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 36, 2007, Pages 1820-1824

  Schlieper, Georg ^a   Brandenburg, V ^a   Djuric, Z ^b   Damjanovic, T ^b   Markovic, N ^b   Westenfeld, R ^a   Dimkovic, N ^b   Ketteler, M ^a   Floege, J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Zvezdara Universitätskrankenhaus ^*

Author keywords

Arterial stiffness; Dialysis efficiency; End stage renal disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FETUIN A; GLYCOPROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALPHA2HS GLYCOPROTEIN; OSTEOPROTEGERIN; PLASMA PROTEIN;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; CORRELATION ANALYSIS; DIALYSIS; FEMORAL ARTERY; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; PULSE WAVE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AGING; ARTERIOSCLEROSIS; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; FEMALE; INTIMA; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PULSE RATE; RENAL REPLACEMENT THERAPY; TUNICA MEDIA;

AGING; ARTERIOSCLEROSIS; BLOOD PRESSURE; BLOOD PROTEINS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PULSE; RENAL DIALYSIS; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA;

EID: 34548415537     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-984969     Document Type: Article

References (26)

1. US Renal Data System. USRDS 1998 annual data report. AJKD 1999; 32 (Suppl 1): 63-90
2. National Kidney Foundation: K/DOQI GUIDELINES 2000. http://www.kidney. org/professionals/kdoqi/guidelines
3. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
4. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439
5. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
6. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
7. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
8. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
9. Haydar AA, Covic A, Colhoun H et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004; 65: 1790-1794
10. Hermans MM, Brandenburg V, Ketteler M et al. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006; 21: 1293-1299
11. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148
12. Ix JH, Shlipak MG, Brandenburg VM et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006; 113: 1760-1767
13. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833
14. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
15. London GM, Marchais SJ, Guerin AP et al. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl 2003; 84: S88-S93
16. Moe SM, Reslerova M, Ketteler M et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-2304
17. Nishizawa Y, Shoji T, Maekawa K et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2003; 41: S76-S79
18. Nitta K, Akiba T, Uchida K et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 2003; 42: 303-309
19. Odamaki M, Shibata T, Takita T et al. Serum fetuin-A and aortic calcification in hemodialysis patients. Kidney Int 2005; 68: 2915
20. Schäfer C, Heiss A, Schwarz A et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366
21. Stenvinkel P, Andersson P, Wang T et al. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med 1999; 246: 503-507
22. Stenvinkel P, Wang K, Qureshi AR et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383-2392
23. Vernaglione L, Cristofano C, Muscogiuri P et al. Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis? Am J Kidney Dis 2004; 43: 471-478
24. Wang AY, Woo J, Lam CW et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-1685
25. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
26. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658